174 related articles for article (PubMed ID: 28271281)
1. The role of radiation in treating glioblastoma: here to stay.
Corso CD; Bindra RS; Mehta MP
J Neurooncol; 2017 Sep; 134(3):479-485. PubMed ID: 28271281
[TBL] [Abstract][Full Text] [Related]
2. Management of GBM: a problem of local recurrence.
Kirkpatrick JP; Laack NN; Shih HA; Gondi V
J Neurooncol; 2017 Sep; 134(3):487-493. PubMed ID: 28378194
[TBL] [Abstract][Full Text] [Related]
3. The role of brachytherapy in the treatment of glioblastoma multiforme.
Barbarite E; Sick JT; Berchmans E; Bregy A; Shah AH; Elsayyad N; Komotar RJ
Neurosurg Rev; 2017 Apr; 40(2):195-211. PubMed ID: 27180560
[TBL] [Abstract][Full Text] [Related]
4. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
5. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
Nieder C; Mehta MP
Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
[TBL] [Abstract][Full Text] [Related]
6. Recent medical management of glioblastoma.
Johnson DR; Chang SM
Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
[TBL] [Abstract][Full Text] [Related]
7. Short course of radiation therapy in elderly patients with glioblastoma multiforme.
Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ
Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921
[TBL] [Abstract][Full Text] [Related]
8. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation.
Yanagihara TK; Saadatmand HJ; Wang TJ
J Neurooncol; 2016 Dec; 130(3):397-411. PubMed ID: 27632018
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
[TBL] [Abstract][Full Text] [Related]
12. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.
Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS
Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
Scoccianti S; Krengli M; Marrazzo L; Magrini SM; Detti B; Fusco V; Pirtoli L; Doino D; Fiorentino A; Masini L; Greto D; Buglione M; Rubino G; Lonardi F; Migliaccio F; Marzano S; Santoni R; Ricardi U; Livi L
Radiol Med; 2018 Jan; 123(1):48-62. PubMed ID: 28879459
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
15. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
Kimple RJ; Grabowski S; Papez M; Collichio F; Ewend MG; Morris DE
Am J Clin Oncol; 2010 Jun; 33(3):265-70. PubMed ID: 19823072
[TBL] [Abstract][Full Text] [Related]
16. State of the art: the evolving role of RT in combined modality therapy for GBM.
Bindra RS; Galanis E; Mehta MP
J Neurooncol; 2017 Sep; 134(3):477-478. PubMed ID: 28913783
[No Abstract] [Full Text] [Related]
17. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
18. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.
Huang J; Samson P; Perkins SM; Ansstas G; Chheda MG; DeWees TA; Tsien CI; Robinson CG; Campian JL
J Neurooncol; 2017 Feb; 131(3):593-601. PubMed ID: 27844308
[TBL] [Abstract][Full Text] [Related]
19. New Hypofractionation Radiation Strategies for Glioblastoma.
Azoulay M; Shah J; Pollom E; Soltys SG
Curr Oncol Rep; 2017 Sep; 19(9):58. PubMed ID: 28735440
[TBL] [Abstract][Full Text] [Related]
20. Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme.
Chen YD; Feng J; Fang T; Yang M; Qiu XG; Jiang T
Chin Med J (Engl); 2013 Jun; 126(12):2320-4. PubMed ID: 23786946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]